Evidence map›Paper›PMID 35949433›Full record

ReviewWorld journal of clinical oncology2022

Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina.

Federico Esteso, Natalia Soledad Tissera, Juan Manuel O'Connor, Romina Luca, Eduardo Huertas, Fernando Sánchez Loria, Ivana Pedraza, Alejandro Pairola, Fernando Brancato, Lisandro Paganini and 10 more

Abstract readReview
In one paragraph

Review in World journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Federico EstesoDepartment of Gastrointestinal Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Natalia Soledad TisseraDepartment of Gastrointestinal Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Juan Manuel O'ConnorDepartment of Gastrointestinal Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Romina LucaDepartment of Gastrointestinal Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Eduardo HuertasDepartment of Surgery, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Fernando Sánchez LoriaDepartment of Surgery, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Ivana PedrazaDepartment of Surgery, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Alejandro PairolaDepartment of Surgery, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Fernando BrancatoDepartment of Surgery, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Lisandro PaganiniDepartment of Radiology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Mariana KucharczykDepartment of Radiology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Mora AmatDepartment of Pathology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Maria Teresa PomboDepartment of Pathology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Mariana GalliDepartment of Radiation Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Luisina BrunoDepartment of Gastrointestinal Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Luis CaroDepartment of Gastroenterology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Andrés RodriguezDepartment of Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Diego EnricoDepartment of Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.
Federico WaisbergDepartment of Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina. federico.esteso@yahoo.com.
Matías ChacónDepartment of Medical Oncology, Instituto Alexander Fleming, Buenos Aires 1426, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the increasing complexity of cancer care, multidisciplinary tumor boards have become essential in daily clinical oncology practice. The Project Extension for Community Healthcare Outcomes (ECHO) initiative developed an innovative telementoring model using a "hub and spoke" design consisting of a team of experts (hub) that offers a full service to multiple participants (the spokes) during regularly scheduled sessions discussing patients' clinical cases. The Alexander Fleming Cancer Institute in Buenos Aires was the first hub in Latin America to implement Project ECHO for gastrointestinal tumors. In our 3-year experience, 80 patients from 37 centers were evaluated within Project ECHO and a range of three to five cases were discussed in each meeting. From our perspective, the impact of this novel approach was a remarkable strategy to reduce care disparities by equalizing access to high-quality medical knowledge in a multidisciplinary environment for medical discussions. Additionally, it was shown to have a cost-effective impact directly on the patients and the local health system, since relevant costs were saved after unnecessary treatments, studies and travel expenses were avoided.

Indexed as

Cancer disparitiesExtension for Community Healthcare Outcomes projectGastrointestinalOncologyTumor boardVirtual

Identifiers

PMID35949433
PMCPMC9244971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.